Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹235 Cr₹198 Cr₹154 Cr₹140 Cr₹114 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹235 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹235 Cr
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2026 ₹235 Cr
18.74
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹722.1 Cr -0.9% -3.9% 8.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-0.9%

-3.9%

8.7%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses